Cumberland Pharmaceuticals
CPIX
20 hedge funds and large institutions have $4.36M invested in Cumberland Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 9 reducing their positions, and 3 closing their positions.
9,800% more call options, than puts
Call options by funds: $297K | Put options by funds: $3K
67% more capital invested
Capital invested by funds: $2.61M → $4.36M (+$1.75M)
1.38% less ownership
Funds ownership: 14.5% → 13.12% (-1.4%)
9% less funds holding
Funds holding: 22 → 20 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
67% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
+$26.9K |
| 2 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
+$1.47K |
| 3 |
CAL
Capital Advisors Ltd
Shaker Heights,
Ohio
|
+$644 |
| 4 |
Bank of New York Mellon
New York
|
+$1 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$151K |
| 2 |
BlackRock
New York
|
-$99.4K |
| 3 |
Renaissance Technologies
New York
|
-$30.9K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$16.3K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$12.8K |
CPIX Hedge Fund Activity: Q4 2024 in Review
20 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q4 2024, worth a combined $4.36M — up 67% from $2.61M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CPIX and 1 opened new positions — a net loss of 2 holders — while 9 trimmed existing stakes and 3 added.
The largest buyer was Two Sigma Investments, adding an estimated $26.9K. The largest seller was Bridgeway Capital Management, cutting an estimated $151K.
- 20 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q4 2024, down from 22 in Q3 2024.
- Funds reported $4.36M of Cumberland Pharmaceuticals stock for Q4 2024, up 67% quarter-over-quarter.
- 1 fund opened new Cumberland Pharmaceuticals positions in Q4 2024 and 3 closed out, a net change of -2 holders.
- The largest Cumberland Pharmaceuticals buyer in Q4 2024 was Two Sigma Investments, an estimated $26.9K added.
- The largest Cumberland Pharmaceuticals seller in Q4 2024 was Bridgeway Capital Management, an estimated $151K sold.
Based on aggregated 13F filings for Q4 2024.